|
1
|
Cheung HC, Leung KY and Choi CH:
Diagnostic accuracy of spot urine protein-to-creatinine ratio for
proteinuria and its association with adverse pregnancy outcomes in
Chinese pregnant patients with pre-eclampsia. Hong Kong Med J.
22:249–255. 2016.PubMed/NCBI
|
|
2
|
Askie LM, Duley L, Henderson-Smart DJ and
Stewart LA; PARIS Collaborative Group, : Antiplatelet agents for
prevention of pre-eclampsia: A meta-analysis of individual patient
data. Lancet. 369:1791–1798. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Turner RJ, Bloemenkamp KW, Bruijn JA and
Baelde HJ: Loss of thrombomodulin in placental dysfunction in
preeclampsia. Arterioscler Thromb Vasc Biol. 36:728–735. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hastie R, Brownfoot FC, Pritchard N,
Hannan NJ, Cannon P, Nguyen V, Palmer K, Beard S, Tong S and
Kaitu'u-Lino TJ: EGFR (epidermal growth factor receptor) signaling
and the mitochondria regulate sFlt-1 (soluble FMS-like tyrosine
kinase-1) secretion. Hypertension. 73:659–670. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang X and Meng T: MicroRNA-431 affects
trophoblast migration and invasion by targeting ZEB1 in
preeclampsia. Gene. 683:225–232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang T, Hu XY, Li YH, Tian BQ, Li ZW and
Fu Q: MicroRNA-21 regulates the proliferation, differentiation, and
apoptosis of human renal cell carcinoma cells by the mTOR-STAT3
signaling pathway. Oncol Res. 24:371–380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu M, Chen Y, Song G, Chen B, Wang L, Li
X, Kong X, Shen Y and Qian L: MicroRNA-29c overexpression inhibits
proliferation and promotes apoptosis and differentiation in P19
embryonal carcinoma cells. Gene. 576:304–311. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou N, Fei D, Zong S, Zhang M and Yue Y:
MicroRNA-138 inhibits proliferation, migration and invasion through
targeting hTERT in cervical cancer. Oncol Lett. 12:3633–3639. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang X, Lei P, Huang Y, Zhang Z and Zhang
Y: MicroRNA-133b inhibits the migration and invasion of non-small
cell lung cancer cells via targeting FSCN1. Oncol Lett.
12:3619–3625. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao G, Zhou X, Chen S, Miao H, Fan H,
Wang Z, Hu Y and Hou Y: Differential expression of microRNAs in
decidua-derived mesenchymal stem cells from patients with
pre-eclampsia. J Biomed Sci. 21:812014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Biró O, Nagy B and Rigó J Jr: Identifying
miRNA regulatory mechanisms in preeclampsia by systems biology
approaches. Hypertens Pregnancy. 36:90–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang S, Li H, Ge Q, Guo L and Chen F:
Deregulated microRNA species in the plasma and placenta of patients
with preeclampsia. Mol Med Rep. 12:527–534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Ge Q, Guo L and Lu Z: Maternal
plasma miRNAs expression in preeclamptic pregnancies. Biomed Res
Int. 2013:9702652013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hromadnikova I, Kotlabova K, Ivankova K,
Vedmetskaya Y and Krofta L: Profiling of cardiovascular and
cerebrovascular disease associated microRNA expression in umbilical
cord blood in gestational hypertension, preeclampsia and fetal
growth restriction. Int J Cardiol. 249:402–409. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi SY, Yun J, Lee OJ, Han HS, Yeo MK,
Lee MA and Suh KS: MicroRNA expression profiles in placenta with
severe preeclampsia using a PNA-based microarray. Placenta.
34:799–804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li XR, Chu HJ, Lv T, Wang L, Kong SF and
Dai SZ: miR-342-3p suppresses proliferation, migration and invasion
by targeting FOXM1 in human cervical cancer. FEBS Lett.
588:3298–3307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie X, Liu H, Wang M, Ding F, Xiao H, Hu
F, Hu R and Mei J: miR-342-3p targets RAP2B to suppress
proliferation and invasion of non-small cell lung cancer cells.
Tumour Biol. 36:5031–5038. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao L and Zhang Y: miR-342-3p affects
hepatocellular carcinoma cell proliferation via regulating NF-κB
pathway. Biochem Biophys Res Commun. 457:370–377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jarvenpaa J, Vuoristo JT, Savolainen ER,
Ukkola O, Vaskivuo T and Ryynanen M: Altered expression of
angiogenesis-related placental genes in pre-eclampsia associated
with intrauterine growth restriction. Gynecol Endocrinol.
23:351–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saito T and Saetrom P: MicroRNAs-targeting
and target prediction. N Biotechnol. 27:243–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang C, Li Q, Ren N, Li C, Wang X, Xie M,
Gao Z, Pan Z, Zhao C, Ren C and Yang W: Placental miR-106a~363
cluster is dysregulated in preeclamptic placenta. Placenta.
36:250–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schatz F, Guzeloglu-Kayisli O, Arlier S,
Kayisli UA and Lockwood CJ: The role of decidual cells in uterine
hemostasis, menstruation, inflammation, adverse pregnancyoutcomes
and abnormal uterine bleeding. Hum Reprod Update. 22:497–515. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Redline RW and Patterson P: Pre-eclampsia
is associated with an excess of proliferative immature intermediate
trophoblast. Hum Pathol. 26:594–600. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ji L, Zhang L, Li Y, Guo L, Cao N, Bai Z,
Song Y, Xu Z, Zhang J, Liu C and Ma X: MiR-136 contributes to
pre-eclampsia through its effects on apoptosis and angiogenesis of
mesenchymal stem cells. Placenta. 50:102–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang W, Wang A, Zhao C, Li Q, Pan Z, Han
X, Zhang C, Wang G, Ji C, Wang G, et al: miR-125b enhances IL-8
production in earlyonset severe preeclampsia by targeting
sphingosine-1-phosphate lyase 1. PLoS One. 11:e01669402016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ding GC, Chen M, Wang YX, Rui C, Xu W,
Ding HJ and Shi ZH: MicroRNA-128a-induced apoptosis in HTR-8/SVneo
trophoblast cells contributes to pre-eclampsia. Biomed
Pharmacother. 81:63–70. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu H, Wang H, Liu M, Bai Y, Li YX, Ji L,
Peng C, Yu Y and Wang YL: MiR-195 participates in the placental
disorder of preeclampsia via targeting activin receptortype-2B in
trophoblastic cell. J Hypertens. 34:1371–1379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hromadnikova I, Kotlabova K, Hympanova L
and Krofta L: Cardiovascular and cerebrovascular disease associated
microRNAs are dysregulated in placental tissues affected with
gestational hypertension, preeclampsia and intrauterine growth
restriction. PLoS One. 10:e01383832015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu L, Zhou H, Lin H, Qi J, Zhu C, Gao Z
and Wang H: Circulating microRNAs are elevated in plasma from
severe preeclamptic pregnancies. Reproduction. 143:389–397. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H
and Yu H: Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p
expression in colon cancer. Am J Transl Res. 6:391–401.
2014.PubMed/NCBI
|
|
32
|
Xue X, Fei X, Hou W, Zhang Y, Liu L and Hu
R: miR-342-3p suppresses cell proliferation and migration by
targeting AGR2 in non-small cell lung cancer. Cancer Lett.
412:170–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang S, Liu L, Lv Z, Li Q, Gong W and Wu
H: MicroRNA-342-3p inhibits the proliferation, migration, and
invasion of osteosarcoma cells by targeting astrocyte-elevated
gene-1 (AEG-1). Oncol Res. 25:1505–1515. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang H, Fan L, Zhan R, Wu S and Niu W:
Expression of microRNA-10a, microRNA-342-3p and their predicted
target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type.
Oncol Lett. 11:345–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tai MC, Kajino T, Nakatochi M, Arima C,
Shimada Y, Suzuki M, Miyoshi H, Yatabe Y, Yanagisawa K and
Takahashi T: miR-342-3p regulates MYC transcriptional activity via
direct repression of E2F1 in human lung cancer. Carcinogenesis.
36:1464–1473. 2015.PubMed/NCBI
|
|
36
|
Wang L, Xu L, Xu M, Liu G, Xing J, Sun C
and Ding H: Obesity-Associated miR-342-3p promotes adipogenesis of
mesenchymal stem cells by suppressing CtBP2 and releasing C/EBPα
from CtBP2 binding. Cell Physiol Biochem. 35:2285–2298. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lan H, Chen W, He G and Yang S: miR-140-5p
inhibits ovarian cancer growth partially by repression of PDGFRA.
Biomed Pharmacother. 75:117–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu H, Han Y, Lou J, Zhang H, Zhao Y,
Győrffy B and Li R: PDGFRA, HSD17B4 and HMGB2 are potential
therapeutic targets in polycystic ovarian syndrome and breast
cancer. Oncotarget. 8:69520–69526. 2017.PubMed/NCBI
|
|
39
|
Kalfusová A and Kodet R: Molecular
mechanisms of primary and secondary resistance, molecular-genetic
features and characteristics of KIT/PDGFRA non-mutated GISTs. Cesk
Patol Winter. 53:167–173. 2017.(In Czech).
|
|
40
|
Bai X, Kong Y, Chi Z, Sheng X, Cui C, Wang
X, Mao L, Tang B, Li S, Lian B, et al: MAPK pathway and TERT
promoter gene mutation pattern and its prognostic value in melanoma
patients: A retrospective study of 2,793 cases. Clin Cancer Res.
23:6120–6127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen W, Kuang Y, Qiu HB, Cao Z, Tu Y,
Sheng Q, Eilers G, He Q, Li HL, Zhu M, et al: Dual targeting of
insulin receptor and KIT in imatinib-resistant gastrointestinal
stromal tumors. Cancer Res. 77:5107–5117. 2017. View Article : Google Scholar : PubMed/NCBI
|
